KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Total Liabilities (2017 - 2025)

Historic Total Liabilities for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $1.6 billion.

  • Guardant Health's Total Liabilities rose 202.87% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 202.87%. This contributed to the annual value of $1.6 billion for FY2024, which is 15.24% down from last year.
  • Guardant Health's Total Liabilities amounted to $1.6 billion in Q3 2025, which was up 202.87% from $1.6 billion recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Total Liabilities registered a high of $1.6 billion during Q2 2025, and its lowest value of $1.4 billion during Q1 2021.
  • In the last 5 years, Guardant Health's Total Liabilities had a median value of $1.6 billion in 2023 and averaged $1.6 billion.
  • Its Total Liabilities has fluctuated over the past 5 years, first skyrocketed by 118339.27% in 2021, then tumbled by 252.89% in 2023.
  • Quarter analysis of 5 years shows Guardant Health's Total Liabilities stood at $1.6 billion in 2021, then fell by 0.62% to $1.5 billion in 2022, then rose by 5.03% to $1.6 billion in 2023, then fell by 0.15% to $1.6 billion in 2024, then grew by 0.37% to $1.6 billion in 2025.
  • Its Total Liabilities stands at $1.6 billion for Q3 2025, versus $1.6 billion for Q2 2025 and $1.6 billion for Q1 2025.